Gabapentin for shingles nerve pain

Gabapentin for shingles nerve pain

In the US, gabapentin is indicated for the treatment of postherpetic neuralgia and as an adjunctive therapy in the treatment of partial-onset seizures without secondary generalization in people with epilepsy. [7] Gabapentin is an anticonvulsant medication prescribed for a variety of conditions. Learn about its uses, side effects, and what you should know if you've been prescribed this medication. Gabapentin is used to help control partial seizures (convulsions) in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to control seizures for as long as you continue to take it. While it can be highly effective and even life-changing for some, gabapentin can also cause side effects, carry risks and is sometimes misused. Gabapentin is a prescription medicine used to treat seizures, pain after shingles, restless legs syndrome, and off-label uses. Learn about side effects, dosage, uses, warnings, interactions, and brand differences. Overview: Gabapentin is used to treat certain people with seizures or nerve pain. Common side effects may include dizziness, sleepiness, or trouble with balance or coordination. Serious side. Gabapentin is a prescription drug most commonly prescribed to relieve nerve pain following shingles in adults and the pain of postherpetic neuralgia. Learn about side effects, drug interactions, dosages, warnings, and more. View gabapentin information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, important safety information and directions for administration. Gabapentin is a prescription medication known as a gamma aminobutyric acid (GABA) analogue. GABA reduces the excitability of nerve cells (neurons) in the brain, which play a role in seizures and the transmission of pain signals. Easy-to-read patient tips for gabapentin covering how it works, benefits, risks, and best practices.

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*